Evidence map›Paper›PMID 41419639›Full record

ArticleApplied microbiology and biotechnology2025

Improvement of arabinoxylan degradation in Clostridium saccharobutylicum DSM 13864

Holger Edelmann, Joseph Rebel, Melanie Baudrexl, Wolfgang Liebl, Armin Ehrenreich

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Holger EdelmannChair of Microbiology, Technical University of Munich, Emil-Ramann-Str. 4, 85354, Freising, Germany.
Joseph RebelChair of Microbiology, Technical University of Munich, Emil-Ramann-Str. 4, 85354, Freising, Germany.
Melanie BaudrexlChair of Microbiology, Technical University of Munich, Emil-Ramann-Str. 4, 85354, Freising, Germany.
Wolfgang LieblChair of Microbiology, Technical University of Munich, Emil-Ramann-Str. 4, 85354, Freising, Germany. wliebl@tum.de.ORCID http://orcid.org/0000-0002-8421-2478
Armin EhrenreichChair of Microbiology, Technical University of Munich, Emil-Ramann-Str. 4, 85354, Freising, Germany. aehrenr@tum.de.ORCID http://orcid.org/0000-0001-9580-3620

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Solventogenic Clostridium species can efficiently produce n-butanol and other valuable chemicals via acetone-butanol-ethanol (ABE) fermentation from plant-based feedstocks. For economic and ecological sustainability, cheap and abundant substrates such as lignocellulosic and hemicellulosic residues from agricultural or forestry side streams are preferable. Cereal brans, rich in hemicellulose, represent a promising substrate. However, for direct fermentation of this material, only low product titers are reported. In this study, we characterized the utilization of arabinoxylan, the main polysaccharide component of cereal bran, by the industrial ABE producer Clostridium saccharobutylicum DSM 13864

Indexed as

ClostridiumGlycoside HydrolasesXylansAcetoneButanolsEthanolFermentationAcetonealpha-N-arabinofuranosidasearabinoxylanButanolsEthanolGlycoside HydrolasesXylansArabinofuranosidaseArabinoxylan degradationCereal branClostridium saccharobutylicumThermoclostridium stercorarium

Identifiers

PMID41419639
PMCPMC12718284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.